Global Amebiasis Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 167

Report ID: 224555

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. 

According to this study, over the next five years the Amebiasis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Amebiasis business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key manufacturers and key regions and countries.

This study considers the Amebiasis value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Metronidazole
Paromomycin
Tinidazole
Other
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Amebiasis consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Amebiasis market by identifying its various subsegments.
Focuses on the key global Amebiasis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amebiasis with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Amebiasis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Amebiasis Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amebiasis Consumption 2013-2023
2.1.2 Amebiasis Consumption CAGR by Region
2.2 Amebiasis Segment by Type
2.2.1 Metronidazole
2.2.2 Paromomycin
2.2.3 Tinidazole
2.2.4 Other
2.3 Amebiasis Consumption by Type
2.3.1 Global Amebiasis Consumption Market Share by Type (2013-2018)
2.3.2 Global Amebiasis Revenue and Market Share by Type (2013-2018)
2.3.3 Global Amebiasis Sale Price by Type (2013-2018)
2.4 Amebiasis Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amebiasis Consumption by Application
2.5.1 Global Amebiasis Consumption Market Share by Application (2013-2018)
2.5.2 Global Amebiasis Value and Market Share by Application (2013-2018)
2.5.3 Global Amebiasis Sale Price by Application (2013-2018)

3 Global Amebiasis by Players
3.1 Global Amebiasis Sales Market Share by Players
3.1.1 Global Amebiasis Sales by Players (2016-2018)
3.1.2 Global Amebiasis Sales Market Share by Players (2016-2018)
3.2 Global Amebiasis Revenue Market Share by Players
3.2.1 Global Amebiasis Revenue by Players (2016-2018)
3.2.2 Global Amebiasis Revenue Market Share by Players (2016-2018)
3.3 Global Amebiasis Sale Price by Players
3.4 Global Amebiasis Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Amebiasis Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Amebiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Amebiasis by Regions
4.1 Amebiasis by Regions
4.1.1 Global Amebiasis Consumption by Regions
4.1.2 Global Amebiasis Value by Regions
4.2 Americas Amebiasis Consumption Growth
4.3 APAC Amebiasis Consumption Growth
4.4 Europe Amebiasis Consumption Growth
4.5 Middle East & Africa Amebiasis Consumption Growth

5 Americas
5.1 Americas Amebiasis Consumption by Countries
5.1.1 Americas Amebiasis Consumption by Countries (2013-2018)
5.1.2 Americas Amebiasis Value by Countries (2013-2018)
5.2 Americas Amebiasis Consumption by Type
5.3 Americas Amebiasis Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Amebiasis Consumption by Countries
6.1.1 APAC Amebiasis Consumption by Countries (2013-2018)
6.1.2 APAC Amebiasis Value by Countries (2013-2018)
6.2 APAC Amebiasis Consumption by Type
6.3 APAC Amebiasis Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Amebiasis by Countries
7.1.1 Europe Amebiasis Consumption by Countries (2013-2018)
7.1.2 Europe Amebiasis Value by Countries (2013-2018)
7.2 Europe Amebiasis Consumption by Type
7.3 Europe Amebiasis Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Amebiasis by Countries
8.1.1 Middle East & Africa Amebiasis Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Amebiasis Value by Countries (2013-2018)
8.2 Middle East & Africa Amebiasis Consumption by Type
8.3 Middle East & Africa Amebiasis Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Amebiasis Distributors
10.3 Amebiasis Customer

11 Global Amebiasis Market Forecast
11.1 Global Amebiasis Consumption Forecast (2018-2023)
11.2 Global Amebiasis Forecast by Regions
11.2.1 Global Amebiasis Forecast by Regions (2018-2023)
11.2.2 Global Amebiasis Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Amebiasis Forecast by Type
11.8 Global Amebiasis Forecast by Application

12 Key Players Analysis
12.1 Dr. Reddy’s Laboratories
12.1.1 Company Details
12.1.2 Amebiasis Product Offered
12.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Dr. Reddy’s Laboratories News
12.2 Mission Pharmacal
12.2.1 Company Details
12.2.2 Amebiasis Product Offered
12.2.3 Mission Pharmacal Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Mission Pharmacal News
12.3 Aceto Corporation
12.3.1 Company Details
12.3.2 Amebiasis Product Offered
12.3.3 Aceto Corporation Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Aceto Corporation News
12.4 Mylan Pharmaceuticals
12.4.1 Company Details
12.4.2 Amebiasis Product Offered
12.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan Pharmaceuticals News
12.5 Impax Laboratories
12.5.1 Company Details
12.5.2 Amebiasis Product Offered
12.5.3 Impax Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Impax Laboratories News
12.6 Pfizer
12.6.1 Company Details
12.6.2 Amebiasis Product Offered
12.6.3 Pfizer Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Pfizer News
12.7 Sanofi
12.7.1 Company Details
12.7.2 Amebiasis Product Offered
12.7.3 Sanofi Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Sanofi News
12.8 Lupin Pharmaceuticals
12.8.1 Company Details
12.8.2 Amebiasis Product Offered
12.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Lupin Pharmaceuticals News
12.9 Glenmark Pharmaceuticals
12.9.1 Company Details
12.9.2 Amebiasis Product Offered
12.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Glenmark Pharmaceuticals News
12.10 Sun Pharmaceutical
12.10.1 Company Details
12.10.2 Amebiasis Product Offered
12.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Sun Pharmaceutical News
12.11 Heritage Pharmaceuticals

13 Research Findings and Conclusion